Welcome to our dedicated page for Ayr Wellness SEC filings (Ticker: AYRWF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AYR Wellness Inc. (AYRWF) SEC filings page provides access to the company’s regulatory disclosures as a foreign issuer, including Form 6‑K current reports that furnish key news releases and material change reports. AYR files under the Securities Exchange Act of 1934 and indicates on its 6‑K covers whether it reports on Form 20‑F or Form 40‑F.
Recent 6‑K filings reference significant restructuring and transaction documents. These include a Material Change Report and a Master Purchase Agreement associated with the transfer of core assets and equity interests of specified subsidiaries to a newly formed acquisition vehicle owned by certain senior noteholders. Other 6‑Ks furnish news releases describing the initiation of proceedings under the Companies’ Creditors Arrangement Act in British Columbia, the result of an Article 9 public foreclosure auction, and the commencement of Article 9 proceedings for collateral assets in multiple U.S. states.
Filings also cover AYR’s announcement of unaudited interim condensed consolidated financial statements and related Management’s Discussion and Analysis (MD&A). In these materials, the company explains its use of non‑GAAP measures such as Adjusted EBITDA and Adjusted Gross Profit and provides reconciliations to the most directly comparable GAAP measures. These disclosures help readers understand how management evaluates the performance of AYR’s cannabis operations and capital structure.
Through this filings page, users can review the sequence of 6‑Ks that document AYR’s Restructuring Support Agreement with senior noteholders, the Bridge Credit Agreement, Article 9 sale steps, and CCAA proceedings. Stock Titan’s platform can pair these filings with AI-powered summaries to clarify the implications of complex documents, highlight key restructuring terms, and explain how non‑GAAP metrics relate to the company’s reported results.
AYR Wellness Inc. reported that Lou Karger has resigned as a director and Chair of the Board, effective January 31, 2026. The company credits Karger with helping guide important phases of its development and publicly thanks him for his leadership and service. The filing notes that his departure is anticipated and includes standard forward-looking statement language highlighting that actual outcomes may differ due to various risks, including those described in AYR’s public filings and broader cannabis industry factors. AYR also reiterates that it operates more than 90 licensed retail locations across several U.S. states and sells a broad portfolio of cannabis products and consumer brands.